Risk Factors of Coronary In–Stent Restenosis in Drug-Eluting Stent: A Systematic Review and Meta-Analysis

Siahaan, Hotmauli; Notobroto, Hari Basuki; Her Oktaviono, Yudi; Siahaan, Paulus Parholong; Budi, David Setyo; Anjaswanti, Rizky Novita

Akses terbuka Jurnal SINTA 1

Risk Factors of Coronary In–Stent Restenosis in Drug-Eluting Stent: A Systematic Review and Meta-Analysis

ACTA MEDICA INDONESIANA · Vol. 57 No. 2 (2025)

ISSN: 2338-2732, 0125-9326
Terbit: 2025-07-08
Penerbit: The Indonesian Society of Internal Medicine
Bahasa: eng
Lisensi: creativecommons.org/licenses/by/4.0

Abstrak

Background: In-stent restenosis (ISR) is an event of coronary atherosclerosis re-budling following the stent implantation in percutaneous coronary intervention. The events of ISR have been significantly reduced since the introduction of drug-eluting stents. However, ISR could still occur, and factors affecting the incident have not yet been discovered. This study aims to evaluate the risk factors of coronary in-stent restenosis in drug-eluting stents. Methods: Studies on the factors and risks of ISR in patients with drug-eluting stents were systematically searched in databases (PubMed, ScienceDirect, Springer, Google Scholar, and ProQuest) on September 20th, 2023. The odds ratio (OR) and mean difference (MD) were analyzed using Review Manager 5.4. Results: Diabetes mellitus (OR 1.73 [95%CI 1.56, 1.91] p < 0.00001) and smoking (OR 1.24 [95%CI 1.13, 1.36] p<0.0001) are the patients' clinical characteristics that are associated with ISR in DES. It is closely related to the contribution of diabetes mellitus in promoting platelet adhesion and smoking in enhancing intimal hyperplasia. As in the angiography characteristics, stent lesion at LAD (OR 1.20 [95%CI 1.07, 1.35] p = 0.002) and stent length (MD 3.61 [95%CI 1.81, 5.42] p < 0.0001) are correlated with the events of ISR. Every millimeter excess of stent length significantly increases the risk of ISR. Therefore, reducing the excess stent length may contribute to the reduced risk of ISR in DES. Conclusion: The identification of risk factors contributing to ISR in DES may help cardiologists modify the attributable factors and prevent the occurrence of ISR.

Kata kunci

Jaringan kolaborasi para penulis

19 penulis · 66 tautan kepenulisan bersama

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

Universitas Airlangga
Afiliasi tidak diketahui

Organisasi berbeda
Organisasi sama
Afiliasi tidak diketahui
Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel

Tampilkan sebagai tabel

Rekan penulis	Organisasi	Artikel bersama
Pudji Lestari	Afiliasi tidak diketahui	1
Puguh Oktavian	Afiliasi tidak diketahui	1
Tri Pudy Asmarawati	Afiliasi tidak diketahui	1
Fauziah Ariviani	Afiliasi tidak diketahui	1
Raka Ihsanulhaj	Afiliasi tidak diketahui	1
Tamara Tsania	Afiliasi tidak diketahui	1
Danise Febiola	Afiliasi tidak diketahui	1
Naomi Lesmana Putri	Afiliasi tidak diketahui	1
Alfian Nur Rosyid	Universitas Airlangga	1
Ifan Ali Wafa	Afiliasi tidak diketahui	1
Nando Reza Pratama	Afiliasi tidak diketahui	1
Henry Sutanto	Afiliasi tidak diketahui	1
Citrawati Dyah Kencono Wungu	Afiliasi tidak diketahui	1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OAI-PMH (metadata jurnal) http://www.actamedindones.org/index.php/ijim/oai, pertama di-harvest 8 Nov 2026, terakhir terlihat 8 Nov 2026.

Metadata asli (oai_dc)

<oai_dc:dc xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Risk Factors of Coronary In–Stent Restenosis in Drug-Eluting Stent: A Systematic Review and Meta-Analysis</dc:title>
	<dc:creator>Siahaan, Hotmauli</dc:creator>
	<dc:creator>Notobroto, Hari Basuki</dc:creator>
	<dc:creator>Her Oktaviono, Yudi</dc:creator>
	<dc:creator>Siahaan, Paulus Parholong</dc:creator>
	<dc:creator>Budi, David Setyo</dc:creator>
	<dc:creator>Anjaswanti, Rizky Novita</dc:creator>
	<dc:subject xml:lang="en-US">Drug-eluting stents</dc:subject>
	<dc:subject xml:lang="en-US">Meta-analysis</dc:subject>
	<dc:subject xml:lang="en-US">Risk factor ISR</dc:subject>
	<dc:subject xml:lang="en-US">Systematic review</dc:subject>
	<dc:subject xml:lang="en-US">cardiology</dc:subject>
	<dc:subject xml:lang="en-US">internal medicine</dc:subject>
	<dc:subject xml:lang="en-US">medical journal</dc:subject>
	<dc:description xml:lang="en-US">Background: In-stent restenosis (ISR) is an event of coronary atherosclerosis re-budling following the stent implantation in percutaneous coronary intervention. The events of ISR have been significantly reduced since the introduction of drug-eluting stents. However, ISR could still occur, and factors affecting the incident have not yet been discovered. This study aims to evaluate the risk factors of coronary in-stent restenosis in drug-eluting stents. Methods: Studies on the factors and risks of ISR in patients with drug-eluting stents were systematically searched in databases (PubMed, ScienceDirect, Springer, Google Scholar, and ProQuest) on September 20th, 2023. The odds ratio (OR) and mean difference (MD) were analyzed using Review Manager 5.4. Results: Diabetes mellitus (OR 1.73 [95%CI 1.56, 1.91] p &amp;lt; 0.00001) and smoking (OR 1.24 [95%CI 1.13, 1.36] p&amp;lt;0.0001) are the patients' clinical characteristics that are associated with ISR in DES. It is closely related to the contribution of diabetes mellitus in promoting platelet adhesion and smoking in enhancing intimal hyperplasia. As in the angiography characteristics, stent lesion at LAD (OR 1.20 [95%CI 1.07, 1.35] p = 0.002) and stent length (MD 3.61 [95%CI 1.81, 5.42] p &amp;lt; 0.0001) are correlated with the events of ISR. Every millimeter excess of stent length significantly increases the risk of ISR. Therefore, reducing the excess stent length may contribute to the reduced risk of ISR in DES. Conclusion: The identification of risk factors contributing to ISR in DES may help cardiologists modify the attributable factors and prevent the occurrence of ISR.</dc:description>
	<dc:publisher xml:lang="en-US">The Indonesian Society of Internal Medicine</dc:publisher>
	<dc:date>2025-07-08</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>http://www.actamedindones.org/index.php/ijim/article/view/2672</dc:identifier>
	<dc:source xml:lang="en-US">Acta Medica Indonesiana; Vol. 57 No. 2 (2025): Acta Medica Indonesiana; 153</dc:source>
	<dc:source>2338-2732</dc:source>
	<dc:source>0125-9326</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>http://www.actamedindones.org/index.php/ijim/article/view/2672/790</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2025 Hotmauli Siahaan, Paulus Parholong Siahaan, Pandit Bagus Tri Saputra, Jannatin Nisa Arnindita, Rizky Novita Anjaswanti, David Setyo Budi, Yudi Her Oktaviono, Hari Basuki Notobroto</dc:rights>
	<dc:rights xml:lang="en-US">https://creativecommons.org/licenses/by/4.0</dc:rights>
</oai_dc:dc>